JSM 2004 - Toronto

JSM Activity #405

This is the preliminary program for the 2004 Joint Statistical Meetings in Toronto, Canada. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 7-10, 2004); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

Back to main JSM 2004 Program page
Legend: = Applied Session, = Theme Session, = Presenter
FRY = Fairmont Royal York, ICH = InterContinental Hotel, TCC = Metro Toronto Convention Center
Add To My Program
405 Thu, 8/12/04, 8:30 AM - 10:20 AM TCC-718 A
Clinical Trials - Contributed - Papers
Biopharmaceutical Section, Biometrics Section
Chair(s): Brian L. Wiens, Amgen, Inc.
     8:35 AM   Analysis of Clinical Trial Data When Treatments Favor Different Endpoints — Leslie A. McClure, University of Michigan; Morton B. Brown, University of Michigan
     8:50 AM   Multiplicity in Clinical Trials involving Multiple Treatment Groups — Kim Hung Lo, Centocor, Inc.; Mani Lakshminarayanan, Centocor, Inc.
     9:05 AM   Multiplicity Adjustments for Clinical Trials with Multiple Doses in Two-dose Regimens — Peng-Liang Zhao, Merck & Co., Inc.; Hui Quan, Merck & Co., Inc.
     9:20 AM   A Comparison of Methodologies for Assessing Onset of Action in Neuropsychiatric Clinical Trials — Craig H. Mallinckrodt, Eli Lilly and Company; Michael Detke, Eli Lilly and Company; Kaiser Christopher, Eli Lilly and Company; John Watkin, Eli Lilly and Company; Geert Molenberghs, Limburgs Universitair Centrum; Raymond J. Carroll, Texas A&M University
     9:35 AM   Stochastic Models for Compliance Analysis and Applications — Junfeng Sun, Ohio State University; Haikady N. Nagaraja, Ohio State University
     9:50 AM   Statistical Validation of Surrgoate Endpoints in HCV Clinical Studies — James Jiao, Roche Laboratories, Inc.; Xiaoping S. Hu, Roche Laboratories, Inc.; Guoqin Su, Novartis
     10:05 AM   Floor Discussion
 

JSM 2004 For information, contact jsm@amstat.org or phone (888) 231-3473. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2004